The published literature does not mention congestive heart failure occurring with bevacizumab. However, the package insert states that 22 (2%) of 1032 patients receiving bevacizumab developed ...

Bevacizumab, a monoclonal antibody against ... dose modifications of irinotecan and fluorouracil (according to the package insert) 10 were permitted in patients with treatment-related adverse ...